Funder
Fundação de Amparo à Pesquisa do Estado de São Paulo
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Institut Pasteur
Financiadora de Estudos e Projetos
Instituto Nacional de Ciência e Tecnologia em Toxinas
Reference46 articles.
1. Organization WH. Malaria vaccine: WHO position paper. Position Paper. World Health Organization; 2022 4/03/2022.
2. Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial;Datoo;Lancet,2021
3. Progress towards the development of a P. vivax vaccine;De;Expert Rev Vaccines,2021
4. Prime-boost vaccination with recombinant protein and adenovirus-vector expressing Plasmodium vivax circumsporozoite protein (CSP) partially protects mice against Pb/Pv sporozoite challenge;de Camargo;Sci Rep,2018
5. Marques RF, Gimenez AM, Aliprandini E, Novais JT, Cury DP, Watanabe IS, et al. Protective Malaria Vaccine in Mice Based on the Plasmodium vivax Circumsporozoite Protein Fused with the Mumps Nucleocapsid Protein. Vaccines. 2020;8(2).